OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Neuroimmune Pharmacology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections	346
Is COVID-19 Gender-sensitive?	115
SARS-CoV-2 Infection Leads to Neurological Dysfunction	73
SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation	55
SARS-CoV-2 Spike Protein Disrupts Blood–Brain Barrier Integrity via RhoA Activation	54
Neuroinflammatory Responses and Parkinson’ Disease: Pathogenic Mechanisms and Therapeutic Targets	42
Infectivity of SARS-CoV-2: there Is Something More than D614G?	40
Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID	37
Pretreatment of Indobufen and Aspirin and their Combinations with Clopidogrel or Ticagrelor Alleviates Inflammasome Mediated Pyroptosis Via Inhibiting NF-κB/NLRP3 Pathway in Ischemic Stroke	37
Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?	36
Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?	33
A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention	32
Lysosomal Stress Response (LSR): Physiological Importance and Pathological Relevance	32
ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy	31
Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses	31
Hydrogen Sulfide Reverses LPS-Induced Behavioral Deficits by Suppressing Microglial Activation and Promoting M2 Polarization	28
STING/NF-κB/IL-6-Mediated Inflammation in Microglia Contributes to Spared Nerve Injury (SNI)-Induced Pain Initiation	27
Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review	27
HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System	27
Stress Enhances Proinflammatory Platelet Activity: the Impact of Acute and Chronic Mental Stress	26
Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder	25
Opioid and neuroHIV Comorbidity – Current and Future Perspectives	25
CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation	23
Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior	22
Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice	22

Apigenin Modulates Dendritic Cell Activities and Curbs Inflammation Via RelB Inhibition in the Context of Neuroinflammatory Diseases	21
Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands	21
Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders	19
Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis	19
Reactive Oxygen Species (ROS) are Critical for Morphine Exacerbation of HIV-1 gp120-Induced Pain	19
HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History	18
HIV-1 gp120-Induced Endolysosome de-Acidification Leads to Efflux of Endolysosome Iron, and Increases in Mitochondrial Iron and Reactive Oxygen Species	18
Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome	17
Neuroprotective Effect of Phthalide Derivative CD21 against Ischemic Brain Injury:Involvement of MSR1 Mediated DAMP peroxiredoxin1 Clearance and TLR4 Signaling Inhibition	17
Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System	16
May the Central Nervous System Be Fogged by the Cytokine Storm in COVID-19?: an Appraisal	16
Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson’s Disease	16
Vancomycin Pretreatment on MPTP-Induced Parkinson’s Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut	16
Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review	15
Astaxanthin Improved the Cognitive Deficits in APP/PS1 Transgenic Mice Via Selective Activation of mTOR	15
Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?	14
The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections	14
Reciprocal Influences of HIV and Cannabinoids on the Brain and Cognitive Function	13
The Role of Plasma Exchange in the Treatment of Refractory Autoimmune Neurological Diseases: a Narrative Review	13
Inhibition of Microglial NLRP3 with MCC950 Attenuates Microglial Morphology and NLRP3/Caspase-1/IL-1β Signaling In Stress-induced Mice	11
Opioid-Mediated HIV-1 Immunopathogenesis	11
Aberrant Immunoglobulin G Glycosylation in Multiple Sclerosis	11